CFD 属于复杂的高风险金融工具,其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作,以及是否能够接受高额亏损的风险。

Scan to Download iOS&Android APP

交易 Jaguar Health, Inc. - JAGX CFD

-
0%
  • 概括
  • 历史数据
  • 活动
  • 收入报表
  • 资产负债表
  • 现金流
  • 所有权
交易条件
价差 -
多头隔夜费

Long position overnight fee


Margin. Your investment $1,000.00
隔夜费用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
-0.024068%
空头隔夜费

Short position overnight fee


Margin. Your investment $1,000.00
隔夜费用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

前往平台
0.001846%
隔夜费时间 21:00 (UTC)
最小交易量 1
货币 USD
保证金 20%
上市交易所 United States of America
交易费 0%

*Information provided by Capital.com

关键数据
前收盘价* N/A
开盘价* N/A
1 年变化* N/A
日范围* N/A
52 周范围 0.73-61.13
平均交易量(10 天) 4.61M
平均交易量(3 个月) 26.39M
市值 14.42M
市盈率 -100.00K
流通股 4.03M
收入 10.78M
EPS -58.95
股息(收益率 %) N/A
贝塔 1.94
下一个财报发布日期 May 8, 2023

所有数据都是由Refinitiv提供的, 除了标有星号的数据, 这是*由 Capital.com 提供的数据

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date 平倉 Change Change (%) 開倉 High Low

Jaguar Health, Inc. Events

時間(協調世界時) (UTC) 國家 事件
No events scheduled
查看所有活動
  • 年度
  • 每季度
2021 2020 2019 2018 2017
总收入 4.335 9.385 5.77526 4.41615 4.36119
收入 4.335 9.385 5.77526 4.41615 4.36119
收入成本,共计 2.333 3.28 3.81581 2.76575 0.88041
毛利 2.002 6.105 1.95945 1.6504 3.48078
总营业费用 45.796 37.896 39.6643 34.5802 39.0853
销售/一般/行政费用,总计 25.997 20.996 20.4389 22.1088 14.3314
研究与开发 15.079 6.413 5.81982 5.15475 4.26946
异常费用(收入) 2.387 7.207 9.58971 4.55093 19.604
营业收入 -41.461 -28.511 -33.889 -30.1641 -34.7241
利息收入(费用),非经营净值 -10.374 -5.488 -4.72125 -2.29767 -0.51429
其他,净值 -0.765 0.19 0.08083 0.31569 0.08855
税前净收入 -52.6 -33.809 -38.5294 -32.1461 -35.1499
税后净收入 -52.6 -33.809 -38.5394 -32.1461 -21.9686
未计算非常项目前的净收益 -52.595 -33.809 -38.5394 -32.1461 -21.9686
净收入 -52.595 -33.809 -38.5394 -32.1461 -21.9686
Total Adjustments to Net Income 0 -4.839 -6.18681
普通股股东可获收益 (不含非经常性项目) -52.595 -38.648 -44.7262 -32.1461 -21.9686
普通股股东可获收益 (含非經常性項目) -52.595 -38.648 -44.7262 -32.1461 -21.9686
摊薄净收入 -52.595 -38.648 -44.7262 -32.1461 -21.9686
摊薄后加权平均股 0.59601 0.1717 0.02206 0.00093 0.01287
扣除特别项目的每股摊薄盈利 -88.2458 -225.09 -2027.26 -34495.6 -1707.42
Dividends per Share - Common Stock Primary Issue
每股正常摊薄盈利 -84.2408 -183.115 -1744.73 -29612.1 -717.051
非常规项目总计 0
少数股东权益 0.005
Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021
总收入 3.15 2.921 2.625 2.08 0.63
收入 3.15 2.921 2.625 2.08 0.63
收入成本,共计 0.613 0.456 0.455 0.469 0.617
毛利 2.537 2.465 2.17 1.611 0.013
总营业费用 13.046 9.4 16.566 12.902 10.159
销售/一般/行政费用,总计 6.493 6.493 8.979 6.951 6.23
研究与开发 5.94 2.451 4.945 5.482 3.312
异常费用(收入) 0 0 2.187 0 0
营业收入 -9.896 -6.479 -13.941 -10.822 -9.529
利息收入(费用),非经营净值 -2.555 -1.827 -5.054 -2.747 -2.643
其他,净值 -0.158 -1.084 0.831 -0.749 -0.02
税前净收入 -12.609 -9.39 -18.164 -14.318 -12.192
税后净收入 -12.609 -9.39 -18.164 -14.318 -12.192
未计算非常项目前的净收益 -12.52 -9.367 -17.986 -14.313 -12.192
净收入 -12.52 -9.367 -17.986 -14.313 -12.192
Total Adjustments to Net Income 0 0
普通股股东可获收益 (不含非经常性项目) -12.52 -9.367 -17.986 -14.313 -12.192
普通股股东可获收益 (含非經常性項目) -12.52 -9.367 -17.986 -14.313 -12.192
摊薄净收入 -12.52 -9.367 -17.986 -14.313 -12.192
摊薄后加权平均股 1.41781 1.06239 0.99178 0.61775 0.61105
扣除特别项目的每股摊薄盈利 -8.83053 -8.81695 -18.1351 -23.1696 -19.9525
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常摊薄盈利 -8.83053 -8.81695 -15.9299 -23.1696 -19.9525
少数股东权益 0.089 0.023 0.178 0.005
  • 年度
  • 每季度
2021 2020 2019 2018 2017
流动资产总额 28.434 17.792 9.52235 8.14994 3.7991
现金和短期投资 17.051 8.09 3.49543 2.56819 0.5207
现金等价物 0.5207
应收账款总额,净额 2.144 4.56 1.69458 1.0018 0.46904
Accounts Receivable - Trade, Net 1.709 4.532 1.69171 0.99568 0.46766
Total Inventory 4.9 2.782 2.12869 3.34218 2.07282
Prepaid Expenses 4.339 2.36 1.26274 1.23777 0.49737
Other Current Assets, Total 0 0.94091 0 0.23917
Total Assets 53.265 42.843 36.4104 41.042 43.6292
Property/Plant/Equipment, Total - Net 1.734 0.677 0.71021 0.76062 1.22207
Other Long Term Assets, Total 0.446 0.037 0.15397 0.42083 0
Total Current Liabilities 15.471 13.22 15.3924 26.6588 15.3858
Accounts Payable 4.929 4.759 5.35154 5.41426 7.35493
Accrued Expenses 7.357 4.493 3.2589 4.93944 2.19955
Notes Payable/Short Term Debt 0 0 0 4.84558 1.14115
Current Port. of LT Debt/Capital Leases 3.184 3.789 6.77846 11.2392 4.28146
Other Current Liabilities, Total 0.001 0.179 0.00349 0.22038 0.40867
Total Liabilities 41.654 25.641 15.8424 26.6588 26.3682
Total Long Term Debt 25.022 12.421 0.45 0 10.9824
Long Term Debt 25.022 12.421 0.45 0 10.9824
Other Liabilities, Total 0.919 0
Total Equity 11.611 17.202 20.568 14.3831 17.261
Redeemable Preferred Stock 0 0 11.6065 9 0
Common Stock 0.005 0.011 0.00546 0.00649 0.01053
Additional Paid-In Capital 231.1 184.09 142.046 99.9274 79.6552
Retained Earnings (Accumulated Deficit) -219.494 -166.899 -133.09 -94.5508 -62.4047
Total Liabilities & Shareholders’ Equity 53.265 42.843 36.4104 41.042 43.6292
Total Common Shares Outstanding 50.4733 40.1279 45.0589 40.4184 42.6378
Goodwill, Net 0 5.21082
Intangibles, Net 22.651 24.337 26.0239 31.7106 33.3972
Cash 17.051 8.09 3.49543 2.56819
Property/Plant/Equipment, Total - Gross 2.032 0.942 0.93428
Accumulated Depreciation, Total -0.298 -0.265 -0.22407
Total Preferred Shares Outstanding 0 0 5.53706
Minority Interest 0.242
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流动资产总额 28.474 28.434 24.005 44.294 44.104
现金和短期投资 17.456 17.051 12.375 21.992 32.25
Cash 17.456 17.051 12.375 21.992 32.25
应收账款总额,净额 2.255 2.144 2.205 4.174 5.927
Accounts Receivable - Trade, Net 1.795 1.709 2.111 4.134 5.897
Total Inventory 4.879 4.9 4.513 3.402 2.821
Prepaid Expenses 3.884 4.339 4.912 4.806 3.106
Other Current Assets, Total 9.92 0
Total Assets 52.906 53.265 59.255 69.539 68.713
Property/Plant/Equipment, Total - Net 1.757 1.734 1.7 1.751 0.674
Property/Plant/Equipment, Total - Gross 2.18 2.032 1.99 2.033 0.948
Accumulated Depreciation, Total -0.423 -0.298 -0.29 -0.282 -0.274
Intangibles, Net 22.229 22.651 23.072 23.494 23.916
Other Long Term Assets, Total 0.446 0.446 10.478 0 0.019
Total Current Liabilities 19.093 15.471 11.951 12.652 12.592
Accounts Payable 3.708 4.929 3.786 4.918 4.74
Accrued Expenses 8.494 7.357 6.381 6.582 6.409
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 6.89 3.184 1.781 1.145 1.431
Other Current Liabilities, Total 0.001 0.001 0.003 0.007 0.012
Total Liabilities 44.861 41.654 37.703 37.754 36.822
Total Long Term Debt 24.783 25.022 24.926 24.195 24.23
Long Term Debt 24.783 25.022 24.926 24.195 24.23
Total Equity 8.045 11.611 21.552 31.785 31.891
Redeemable Preferred Stock 0 0 0 0 0
Common Stock 0.008 0.005 0.005 0.014 0.013
Additional Paid-In Capital 245.517 231.1 226.728 224.76 210.786
Retained Earnings (Accumulated Deficit) -237.48 -219.494 -205.181 -192.989 -178.908
Total Liabilities & Shareholders’ Equity 52.906 53.265 59.255 69.539 68.713
Total Common Shares Outstanding 79.1948 50.4733 48.2117 47.8944 44.7563
Total Preferred Shares Outstanding 0 0 0 0 0
Other Liabilities, Total 0.921 0.919 0.826 0.907
Minority Interest 0.064 0.242
  • 年度
  • 每季度
2021 2020 2019 2018 2017
净收入/起跑线 -52.6 -33.809 -38.5394 -32.1461 -21.9686
经营活动产生的现金 -34.97 -15.278 -20.4568 -22.7308 -9.82494
经营活动产生的现金 1.719 1.727 1.73708 1.319 0.58434
非现金物品 13.644 20.271 17.0073 9.02132 20.6123
已付现金利息 0.028 0.757 0.142 0.01934 0.23455
营运资金的变化 2.267 -3.467 -0.66177 -0.9251 4.12831
投资活动产生的现金 -0.006 -0.007 0 -0.00653 -1.55734
资本支出 -0.006 -0.007 -0.00653 0
其他投资现金流量项目,总计 0 0 -1.55734
融资活动产生的现金 43.937 19.492 21.772 24.5457 10.6799
融资现金流项目 -0.731 -1.008 -2.57481 -2.11755 0
股票的发行(报废),净额 35.615 7.756 24.4468 25.8797 10.302
债务的发行(退还),净额 9.053 12.744 -0.1 0.78349 0.37791
现金净变化 8.961 4.207 1.31519 1.80832 -0.70241
Deferred Taxes 0 -13.1812
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -18.164 -52.6 -38.282 -26.09 -12.009
Cash From Operating Activities -7.695 -34.97 -26.047 -16.615 -6.708
Cash From Operating Activities 0.426 1.719 1.29 0.861 0.431
Non-Cash Items 7.583 13.644 10.601 7.609 4.695
Cash Interest Paid 0.011 0.028 0.021 0.008 0.006
Changes in Working Capital 2.46 2.267 0.344 1.005 0.175
Cash From Investing Activities -0.006 -10.484 -0.006 0
Capital Expenditures -0.006 -0.006 -0.006 0
Cash From Financing Activities 8.15 43.937 40.816 40.443 30.868
Financing Cash Flow Items -0.335 -0.731 -0.623 -0.268 -0.095
Issuance (Retirement) of Stock, Net 9.11 35.615 32.386 31.608 21.86
Issuance (Retirement) of Debt, Net -0.625 9.053 9.053 9.103 9.103
Net Change in Cash 0.405 8.961 4.285 23.822 24.16
Other Investing Cash Flow Items, Total -10.478
Foreign Exchange Effects -0.05

为什么选择 Capital.com?让我们的数字来说话。

Capital.com Group

500K+

交易者

92K+

每月活跃客户

$53M+

每月投资额

$30M+

每月提取金额

交易計算器

如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。

貿易佣金
0
  • 1:1
杠杆
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
開倉

平倉

做空 做多

Jaguar Health, Inc. Company profile

关于 Jaguar Health Inc

Jaguar Health, Inc.是一家处于商业阶段的制药公司。 公司致力于开发以植物为基础的、非阿片类的、可持续提取的处方药,用于治疗人们和动物的胃肠道(GI)不适,包括慢性和衰弱性腹泻。 公司通过两个部门运营:人类健康和动物健康。 动物健康部门专注于开发和商业化用于伴侣动物和生产动物的处方和非处方产品。 其Canalevia-CA1用于治疗狗的化疗引起的腹泻。 人类健康部门专注于人类产品的开发和商业化,以及正在进行的Mytesi的商业化,该产品用于人类免疫缺陷病毒(HIV)/获得性免疫缺陷综合症(AIDS)成人患者在抗逆转录病毒治疗中的非感染性腹泻的症状缓解。 其全资子公司是Napo Pharmaceuticals, Inc.

Industry: Bio Therapeutic Drugs

200 Pine Street Suite 400
SAN FRANCISCO
CALIFORNIA 94104
US

收入报表

  • Annual
  • Quarterly

人们也观看

US100

12,832.90 Price
+1.660% 1D Chg, %
多头隔夜费 -0.0241%
空头隔夜费 0.0018%
隔夜费时间 21:00 (UTC)
价差 1.8

Gold

1,966.41 Price
-0.380% 1D Chg, %
多头隔夜费 -0.0087%
空头隔夜费 0.0005%
隔夜费时间 21:00 (UTC)
价差 0.30

XRP/USD

0.56 Price
+5.690% 1D Chg, %
多头隔夜费 -0.0753%
空头隔夜费 0.0069%
隔夜费时间 21:00 (UTC)
价差 0.00526

BTC/USD

28,381.40 Price
+3.880% 1D Chg, %
多头隔夜费 -0.0616%
空头隔夜费 0.0137%
隔夜费时间 21:00 (UTC)
价差 66.00

还在找一位您可以信任的经纪商吗?

加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。

1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易